Valuation: ResMed, Inc.

Market Cap 29.41B 25.79B 23.89B 21.98B 41.57B 2,815B 42.38B 285B 112B 1,382B 110B 108B 4,773B P/E 2026 *
19.3x
P/E 2027 * 18.1x
Enterprise Value 28.56B 25.05B 23.2B 21.35B 40.37B 2,733B 41.16B 276B 108B 1,342B 107B 105B 4,635B EV / Sales 2026 *
5.05x
EV / Sales 2027 * 4.67x
Free-Float
75.61%
Yield 2026 *
1.19%
Yield 2027 * 1.29%
1 day-2.83%
1 week-9.40%
Current month+1.53%
1 month+2.66%
3 months-14.07%
6 months-22.30%
Current year-17.85%
1 week 190.25
Extreme 190.25
219.98
1 month 184.65
Extreme 184.65
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-2.91%-9.40%-22.13%-9.52% 29.41B
+0.99%+2.71%+24.98%+0.94% 196B
+1.10%-5.02%-20.40%+18.48% 144B
+0.31%+3.03%+0.88%-16.46% 141B
+0.15%+0.47%-57.05%-15.12% 66.54B
+0.29%-3.00%+17.94%-0.83% 53.09B
+2.80%+1.95%-22.68%-30.55% 44.12B
-0.47%+2.31%+11.28%+11.96% 37.93B
-0.78%-1.40%+22.82%+38.75% 36.96B
+1.72%+1.60%-11.52%-19.07% 29.43B
Average +0.33%-0.95%-5.59%-2.14% 77.83B
Weighted average by Cap. +0.61%-0.90%-1.91%-1.06%

Financials

2026 *2027 *
Net sales 5.65B 4.96B 4.59B 4.22B 7.99B 541B 8.14B 54.71B 21.46B 266B 21.22B 20.75B 917B 5.96B 5.22B 4.84B 4.45B 8.42B 570B 8.58B 57.66B 22.61B 280B 22.36B 21.87B 967B
Net income 1.55B 1.36B 1.26B 1.16B 2.19B 148B 2.23B 14.99B 5.88B 72.76B 5.81B 5.69B 251B 1.64B 1.44B 1.33B 1.23B 2.32B 157B 2.36B 15.88B 6.23B 77.09B 6.16B 6.02B 266B
Net Debt -849M -745M -690M -635M -1.2B -81.27B -1.22B -8.22B -3.22B -39.91B -3.19B -3.12B -138B -1.59B -1.39B -1.29B -1.19B -2.25B -152B -2.29B -15.38B -6.03B -74.64B -5.96B -5.83B -258B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
14/07/26 USD 197.87 -2.94% 764,421
10/07/26 USD 203.87 -2.20% 1,331,149
09/07/26 USD 208.45 +1.27% 1,479,036
08/07/26 USD 205.84 -6.33% 1,761,755
07/07/26 USD 219.75 +0.62% 1,726,352
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
203.87USD
Average target price
253.73USD
Spread / Average Target
+24.46%

Quarterly revenue - Rate of surprise